Meet Valinor Pharma. Meaningful therapies. Available to all.

Scientific advances in medicine have the potential to change lives. Yet the very patients who need them are often unable to get them.

Valinor Pharma is a pharmaceutical company focused on innovative commercialization of medicines that not only bring meaningful benefit to patients but also ensure that when a healthcare provider prescribes them to the patients they serve, their patients are able to get them easily and affordably.

Our Mission

Valinor strives to bring significant value and impact to patients, healthcare providers, and investors.

It was founded on the simple but powerful belief that serving patients is foremost and successful commercialization of therapies is achievable in today’s market. By applying commercial expertise and innovation guided by analytics, we can help address the market challenges that stand between providers, patients, and their medications.

Our Approach

Valinor relaunches or brings to market therapeutically differentiated products with disciplined execution, using the same methodical rigor and fact-based principles used to develop the molecules and scientific breakthroughs. And we make these products accessible by breaking down the barriers that prevent patients from getting the products their healthcare providers prefer to prescribe.

Movantik

Our Products

MOVANTIK® (naloxegol) is designed specifically with the patients’ needs in mind. Learn more at MOVANTIK.com and see full Prescribing Information

To report SUSPECTED ADVERSE REACTIONS, contact Valinor Pharma at 1-877-592-2337 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Partner with Us

Help make better medicines possible and accessible.

Valinor is actively looking to acquire or in-license—new launch and currently marketed—prescription products in need of commercial strategies and execution that meet today’s challenges. Contact us today.

Contact Us

Valinor Pharma, LLC
150 N. Riverside Plaza – Suite 3480
Chicago, IL 60606
1-833-233-0115
info@valinorrx.com

Back To Top